Search
Now showing items 1-2 of 2
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Ruecker, Frank G. et al. (2019)
Wissenschaftlicher Artikel
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial
Paschka, Peter et al. (2018)
Wissenschaftlicher Artikel